about
APOBEC3A is implicated in a novel class of G-to-A mRNA editing in WT1 transcriptsPharmacological inhibition of carbonic anhydrase XII interferes with cell proliferation and induces cell apoptosis in T-cell lymphomasAcute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiationLeukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction.Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells.Heterogeneous sensitivity of human acute myeloid leukemia to β-catenin down-modulation.Pharmacological targeting of NF-kappaB potentiates the effect of the topoisomerase inhibitor CPT-11 on colon cancer cells.BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic miceA niche-like culture system allowing the maintenance of primary human acute myeloid leukemia-initiating cells: a new tool to decipher their chemoresistance and self-renewal mechanisms.Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy.A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia.β-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells."Microenvironmental contaminations" induced by fluorescent lipophilic dyes used for noninvasive in vitro and in vivo cell tracking.Overexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis.Acute myeloid leukemia xenograft success prediction: Saving time.Frequency and Dynamics of Leukemia-Initiating Cells during Short-term Ex Vivo Culture Informs Outcomes in Acute Myeloid Leukemia Patients.[Fighting cancer via NF-kappa B inhibition]Aerodynamically assisted bio-jetting of hematopoietic stem cellsL-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia
P50
Q28259425-40B47EDB-EBC3-49BA-B4DF-2AC3D9F56BE0Q28284140-9762EFF0-50F6-4A02-BA07-50617BA8AB31Q33409425-01DBA69E-54A5-44BD-87E3-4A142C9E2397Q33722630-B257E4A6-1889-4E2D-89A1-B9E51F1B7B11Q33902421-0426A76F-CAC4-4897-A7EB-213C97E774D5Q34905557-EAE12A0B-80C6-4BDD-AE6C-57592C323E78Q36614702-DA414EC1-45CC-4CEC-BDA6-035A06F92AE2Q37197900-A7458ABB-850B-4D3D-B11A-85F35502AF55Q37681007-C173CADB-FBB3-4692-9574-78038B6C3FCBQ38858729-77DB0A2D-BE2E-47CA-89FF-28F98F3AD835Q38897087-F3E61770-8557-4CB8-967A-EA4C1750B947Q39620290-34E8F44E-DF2A-400D-A845-4476A80CBEF7Q39730071-22E59382-DF96-4698-8BA7-425DF0C33236Q42113668-EB5386D0-666C-43C6-9993-2ECFF9C0A0DEQ49662874-3A3E9C6F-6A80-40B6-9E70-57B300F2449BQ52881444-C2ECB203-CAB3-4190-91B4-B23249788071Q53377192-A25E4437-DB9A-4894-BB36-2EB251876C66Q60315307-75B962D8-F798-4A53-8C1D-30587D58EA87Q60877151-DFE5B582-B107-45E8-AFC7-77B63577A469
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Emmanuel Griessinger
@ast
Emmanuel Griessinger
@en
Emmanuel Griessinger
@es
Emmanuel Griessinger
@nl
Emmanuel Griessinger
@sl
type
label
Emmanuel Griessinger
@ast
Emmanuel Griessinger
@en
Emmanuel Griessinger
@es
Emmanuel Griessinger
@nl
Emmanuel Griessinger
@sl
prefLabel
Emmanuel Griessinger
@ast
Emmanuel Griessinger
@en
Emmanuel Griessinger
@es
Emmanuel Griessinger
@nl
Emmanuel Griessinger
@sl
P106
P21
P31
P496
0000-0001-7529-4187